Due to the complex and often competing management decisions of Heart Failure, having a continuous, noninvasive hemodynamic profile may help a clinician manage hemodynamic instability early in acute exacerbations. Also, patient’s with a history of Heart Failure pose a unique challenge to clinicians when they are being treated for other medical diagnoses. Measuring stroke volume changes in response to a fluid challenge will provide the clinician with a reliable way to judge fluid responsiveness and help titrate IV fluid in these critical patients.
WHY ARE HEART FAILURE PATIENTS LIKELY TO BENEFIT FROM CHEETAH TECHNOLOGY?
Both the CHEETAH NICOM and the Starling SV provide continuous, 100% noninvasive hemodynamic data with simple-to-use protocols for dynamic assessments. Advanced hemodynamic data can be used to titrate medications and dynamic assessments with Cheetah technology can be used to help titrate IV fluid.
Early detection of hemodynamic instability, cardiac function and fluid imbalance is important for CHF patients, and continuous monitoring of key hemodynamic variables is vital to determine when to supplement therapy with fluids or other medications such as inotropes or vasopressors.